CD90(+) mesothelial-like cells in peritoneal fluid promote peritoneal metastasis by forming a tumor permissive microenvironment

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Kitayama, Joji ^a   Emoto, Shigenobu ^a   Yamaguchi, Hironori ^a   Ishigami, Hironori ^a   Watanabe, Toshiaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; DASATINIB; SEPRASE; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CARCINOGENESIS; CARTILAGE CELL; CD90+ MESOTHELIAL LIKE CELL; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN MKN45; CONTROLLED STUDY; FEMALE; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MESOTHELIUM CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; NUDE MOUSE; OSTEOCYTE; PERITONEAL FLUID; PERITONEUM METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; STOMACH CANCER; T LYMPHOCYTE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, THY-1; CELL DIFFERENTIATION; COLLAGEN TYPE I; EPITHELIUM; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MYOFIBROBLASTS; PERITONEAL NEOPLASMS; PERITONEUM; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84907020981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086516     Document Type: Article

References (53)

1. Koga S, Kaibara N, Iitsuka Y, Kudo H, Kimura A, et al. (1984) Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol 108: 236-238. (Pubitemid 14057507)
2. Sodek KL, Murphy KJ, Brown TJ, Ringuette MJ (2012) Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev 31: 397-414.
3. Mueller MM, Fusenig NE (2004) Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849. (Pubitemid 39472951)
4. Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70: 498-505.
5. Mutsaers SE (2004) The mesothelial cell. Int J Biochem Cell Biol 36: 9-16.
6. Cailleau R, Mackay B, Young RK, Reeves WJ, Jr. (1974) Tissue culture studies on pleural effusions from breast carcinoma patients. Cancer Res 34: 801-809.
7. Whitehead RH, Hughes LE (1975) Tissue culture studies of malignant effusions. Br J Cancer 32: 512-518.
8. Betjes MG, Bos HJ, Krediet RT, Arisz L (1991) The mesothelial cells in CAPD effluent and their relation to peritonitis incidence. Perit Dial Int 11: 22-26.
9. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, et al. (2003) Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348: 403-413. (Pubitemid 36159357)
10. Fang CC, Yen CJ, Chen YM, Shyu RS, Tsai TJ, et al. (2000) Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: effects on TGF-beta. Kidney Int 57: 2626-2633.
11. Rampino T, Cancarini G, Gregorini M, Guallini P, Maggio M, et al. (2001) Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. Am J Pathol 159: 1275-1285. (Pubitemid 32947957)
12. Foley-Comer AJ, Herrick SE, Al-Mishlab T, Prele CM, Laurent GJ, et al. (2002) Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 115: 1383-1389. (Pubitemid 34428696)
13. Yanagidani S, Uozumi N, Ihara Y, Miyoshi E, Yamaguchi N, et al. (1997) Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1- 6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells. J Biochem 121: 626-632. (Pubitemid 27145920)
14. Rodriguez EF, Monaco SE, Khalbuss W, Austin RM, Pantanowitz L (2013) Abdominopelvic washings: A comprehensive review. Cytojournal 10: 7.
15. Singh G, Dekker A, Ladoulis CT (1978) Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology. Acta Cytol 22: 487-489. (Pubitemid 9101245)
16. Mutsaers SE (2002) Mesothelial cells: their structure, function and role in serosal repair. Respirology 7: 171-191.
17. Lansley SM, Searles RG, Hoi A, Thomas C, Moneta H, et al. (2011) Mesothelial cell differentiation into osteoblast- and adipocyte-like cells. J Cell Mol Med 15: 2095-2105.
18. Ho CM, Chang SF, Hsiao CC, Chien TY, Shih DT (2012) Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma. J Biomed Sci 19: 23.
19. Herrick SE, Mutsaers SE (2004) Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol 36: 621-642. (Pubitemid 38316819)
20. Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2: 313-319. (Pubitemid 351467394)
21. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
22. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17: 331-340.
23. Tolar J, Le Blanc K, Keating A, Blazar BR (2010) Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28: 1446-1455.
24. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228. (Pubitemid 32295155)
25. Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242. (Pubitemid 30340601)
26. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, et al. (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549. (Pubitemid 36988070)
27. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S (2000) Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 97: 13625-13630.
28. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, et al. (2001) Circulating skeletal stem cells. J Cell Biol 153: 1133-1140.
29. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301. (Pubitemid 44464698)
30. Lv ZD, Wang HB, Dong Q, Kong B, Li JG, et al. (2013) Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo. Mol Cell Biochem 377: 177-185.
31. Lv ZD, Na D, Ma XY, Zhao C, Zhao WJ, et al. (2011) Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ss1 in vitro. Int J Mol Med 27: 187-193.
32. Tsukada T, Fushida S, Harada S, Yagi Y, Kinoshita J, et al. (2012) The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer. Int J Oncol 41: 476-482.
33. Barcellos-Hoff MH, Park C, Wright EG (2005) Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer 5: 867-875. (Pubitemid 41746031)
34. Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7: 139-147. (Pubitemid 46160989)
35. Egeblad M, Rasch MG, Weaver VM (2010) Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22: 697-706.
36. Nabha SM, dos Santos EB, Yamamoto HA, Belizi A, Dong Z, et al. (2008) Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner. Int J Cancer 122: 2482-2490. (Pubitemid 351590480)
37. Koenig A, Mueller C, Hasel C, Adler G, Menke A (2006) Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res 66: 4662-4671.
38. Dobbie JW (1992) Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 12: 14-27.
39. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736.
40. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L (2006) Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107: 1484-1490. (Pubitemid 43242385)
41. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, et al. (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111: 1327-1333. (Pubitemid 351213419)
42. Rafii A, Mirshahi P, Poupot M, Faussat AM, Simon A, et al. (2008) Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. PLoS One 3: e3894.
43. Martinet L, Poupot R, Mirshahi P, Rafii A, Fournie JJ, et al. (2010) Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses. Int J Cancer 126: 2143-2152.
44. Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, et al. (2010) Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int J Cancer 126: 2090-2101.
45. Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, et al. (2004) Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 114: 1308-1316. (Pubitemid 40385302)
46. Abdollahi A, Li M, Ping G, Plathow C, Domhan S, et al. (2005) Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 201: 925-935. (Pubitemid 40524462)
47. Wang S, Wilkes MC, Leof EB, Hirschberg R (2005) Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J 19: 1-11. (Pubitemid 40069914)
48. Akhmetshina A, Dees C, Pileckyte M, Maurer B, Axmann R, et al. (2008) Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB J 22: 2214-2222. (Pubitemid 351948641)
49. Iwamoto N, Distler JH, Distler O (2011) Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trials. Curr Rheumatol Rep 13: 21-27.
50. Gordon JK, Spiera RF (2010) Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis. Curr Opin Rheumatol 22: 690-695.
51. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, et al. (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62: 3603-3608. (Pubitemid 34728832)
52. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563. (Pubitemid 47525152)
53. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, et al. (2009) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4: e4992.